related documents
- A psychoeducation trial for people with chronic stable angina Conference Paper
- Baseline plasma NT-proBNP concentrations in relation to clinical characteristics: Results from the irbesartan in heart failure with preserved systolic function trial Conference Paper
- Cardiac structural changes and diastolic function in heart failure with preserved ejection fraction - Importance of left atrial volume: the iPRESERVE study Conference Paper
- Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the heart outcomes prevention evaluation (HOPE) Study Conference Paper
- Effect of intravenous iron sucrose on exercise tolerance in anemic and non-anemic patients with symptomatic chronic heart failure and iron deficiency: A randomised, controlled, observer-blinded trial (FERRIC-HF) Conference Paper
- Effects of fondaparinux in patients with ST-Segment elevation acute myocardial infarction non-eligible for reperfusion treatment Conference Paper
- Endothelial anticoagulant heparan sulfate mediates anti-inflammatory effects of antithrombin in sepsis. Conference Paper
- Endothelin-1 antagonism and nitric oxide augmentation prevents CyA induced vasomotor impairment Conference Paper
- Fasting plasma glucose is an independent predictor of hospitalization for congestive heart failure in high-risk patients Conference Paper
- Fondaparinux versus control (placebo or unfractionated heparin) as an adjunct to thrombolytic therapy in acute myocardial infarction: an OASIS 6 substudy Conference Paper
- Guideline adherent antithrombotic treatment is associated with improved cardiovascular outcome compared to undertreatment in real-life atrial fibrillation patients at high risk for stroke Conference Paper
- High heritabilities of serum metabolites and differential metabolomic profiles in families burdened with early onset coronary artery disease Conference Paper
- Impact of vascular events on mortality in AF patients: Insights from ACTIVE W Conference Paper
- Incidence of heparin-induced thrombocytopenia lower than expected patients with acute coronary syndromes. The global registry of acute coronary events Conference Paper
- Increase in risk of death in early months following hospitalization for heart failure: Observations from the CHARM program Conference Paper
- Lack of interaction between angiotensin receptor blocker and aspirin in patients with heart failure Conference Paper
- Long term effects of ultrasound-mediated VEGF165 delivery on microvascular perfusion and endogenous growth factor expression chronic ischemia Conference Paper
- Long-term adherence to the ACC/AHA class I post-discharge medications and recommendations using optimal medical therapy in 2,287 patients with established coronary heart disease: Interim data from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial Conference Paper
- Major bleeding in patients with acute coronary syndrome undergoing early invasive management can be reduced by fondaparinux, even in the context of trans-radial coronary intervention: Insights from OASIS-5 trial Conference Paper
- Neither ramipril nor vitamin E reduces the incidence of atrial fibrillation. Results of the HOPE study. Conference Paper
- Noninvasive measures of subclinical atherosclerosis in children, a systematic overview Conference Paper
- Should we abandon the paradigm of withholding oral anticoagulation in paroxysmal atrial fibrillation? Conference Paper